BusinessUpdated 23 min ago
USFDA issues 7 observations to NATCO Pharma's Hyderabad facility

NATCO Pharma says the observations are believed to be procedural in nature and is confident of addressing them in time
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.


